Blueprint Medicines (BPMC) News Today $82.53 +1.69 (+2.09%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Russell Investments Group Ltd. Buys 16,874 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Russell Investments Group Ltd. increased its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 15.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,902 shares of the biotechnology company's stock afterApril 14 at 4:23 AM | marketbeat.comF M Investments LLC Invests $2.73 Million in Blueprint Medicines Co. (NASDAQ:BPMC)F M Investments LLC acquired a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 31,313 shares of the biotechnology company's stock,April 13 at 6:16 AM | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Hits New 12-Month Low - Time to Sell?Blueprint Medicines (NASDAQ:BPMC) Hits New 52-Week Low - Here's What HappenedApril 12 at 5:16 AM | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Trading Down 5.8% - Here's WhyBlueprint Medicines (NASDAQ:BPMC) Trading Down 5.8% - Time to Sell?April 11 at 12:55 PM | marketbeat.comGeode Capital Management LLC Buys 9,914 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Geode Capital Management LLC raised its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,490,101 shares of the biotechnology company's stApril 11 at 4:30 AM | marketbeat.comBlueprint Medicines' (BPMC) Buy Rating Reiterated at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $133.00 price objective on shares of Blueprint Medicines in a research report on Tuesday.April 10, 2025 | marketbeat.comCalifornia Public Employees Retirement System Sells 24,735 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)California Public Employees Retirement System trimmed its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 24.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,450 shareApril 9, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Bought by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA raised its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 269,990 shares of the biotechnology company's stock afterApril 8, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Reaches New 12-Month Low - What's Next?Blueprint Medicines (NASDAQ:BPMC) Reaches New 12-Month Low - Here's What HappenedApril 7, 2025 | marketbeat.comSchroder Investment Management Group Sells 57,865 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Schroder Investment Management Group lowered its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 60.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,434 shares of the biotechnology compApril 7, 2025 | marketbeat.comNorges Bank Buys New Shares in Blueprint Medicines Co. (NASDAQ:BPMC)Norges Bank purchased a new position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 711,164 shares of the biotechnology company's stock, vaApril 5, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Stock Holdings Increased by Cinctive Capital Management LPCinctive Capital Management LP grew its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 29.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 96,048 shares of the biotechnoloApril 4, 2025 | marketbeat.comTrexquant Investment LP Grows Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)Trexquant Investment LP grew its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 7.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 127,098 shares of the biotechnology company's stock afApril 4, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Holdings Lowered by Alliancebernstein L.P.Alliancebernstein L.P. trimmed its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,138,022 shares of the biotechnology company's stock afterApril 4, 2025 | marketbeat.comNomura Asset Management Co. Ltd. Sells 4,844 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)Nomura Asset Management Co. Ltd. lowered its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,713 shares of the biotechnology compaApril 4, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 66,018 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)JPMorgan Chase & Co. cut its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,155,634 shares of the biotechnology company's stock after selling 66,018April 4, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Acquired by Wellington Management Group LLPWellington Management Group LLP increased its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 8.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,281,364April 3, 2025 | marketbeat.comClearbridge Investments LLC Increases Stake in Blueprint Medicines Co. (NASDAQ:BPMC)Clearbridge Investments LLC increased its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 1.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 490,779 shares of the biotechnology compaApril 3, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. increased its stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 1.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,774,884 shares of the biotechnology company's stocApril 2, 2025 | marketbeat.comSei Investments Co. Grows Position in Blueprint Medicines Co. (NASDAQ:BPMC)Sei Investments Co. boosted its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 70,384 shares of the biotechnology company's stock after buying an additional 6,411 shaApril 2, 2025 | marketbeat.comKLP Kapitalforvaltning AS Makes New $1.13 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC)KLP Kapitalforvaltning AS bought a new stake in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 12,900 shares of the biotechnology company's stock, valued at approximateApril 1, 2025 | marketbeat.comBlueprint Medicines to Present at 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | prnewswire.comPrudential Financial Inc. Has $8.77 Million Position in Blueprint Medicines Co. (NASDAQ:BPMC)Prudential Financial Inc. grew its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 100,538 shares of the biotechnology company's stock after buyingMarch 31, 2025 | marketbeat.comPictet Asset Management Holding SA Boosts Stake in Blueprint Medicines Co. (NASDAQ:BPMC)Pictet Asset Management Holding SA increased its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,183,682March 30, 2025 | marketbeat.comBIT Capital GmbH Boosts Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)BIT Capital GmbH grew its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 78,921 shares of the biotechnology company's stock after purchasing an aMarch 28, 2025 | marketbeat.comTeacher Retirement System of Texas Grows Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Teacher Retirement System of Texas lifted its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 25.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,760 shares of the biotechnology company's stock after pMarch 28, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) COO Sells $216,075.48 in StockBlueprint Medicines Co. (NASDAQ:BPMC - Get Free Report) COO Christina Rossi sold 2,274 shares of Blueprint Medicines stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $95.02, for a total transaction of $216,075.48. Following the transaction, the chief operating officer now directly owns 69,266 shares in the company, valued at approximately $6,581,655.32. This trade represents a 3.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.March 27, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) COO Christina Rossi Sells 2,274 SharesMarch 27, 2025 | insidertrades.comEFG Asset Management North America Corp. Boosts Position in Blueprint Medicines Co. (NASDAQ:BPMC)EFG Asset Management North America Corp. grew its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 120.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,300 sharMarch 26, 2025 | marketbeat.comAmerican Century Companies Inc. Buys 24,132 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)American Century Companies Inc. grew its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 3.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 839,203 shares of the biotechnology company's stock afterMarch 26, 2025 | marketbeat.comIs Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street AnalystsMarch 26, 2025 | msn.comEmerald Advisers LLC Increases Stake in Blueprint Medicines Co. (NASDAQ:BPMC)Emerald Advisers LLC grew its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 10.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 416,866 shares of the biotechnology company's stock after buying an additional 41,000 shMarch 24, 2025 | marketbeat.comFox Run Management L.L.C. Grows Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)Fox Run Management L.L.C. boosted its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 262.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,264 shares of the biotechnology compMarch 24, 2025 | marketbeat.comKnights of Columbus Asset Advisors LLC Invests $1.10 Million in Blueprint Medicines Co. (NASDAQ:BPMC)Knights of Columbus Asset Advisors LLC purchased a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 12,652 shares of the bMarch 24, 2025 | marketbeat.com3,084 Shares in Blueprint Medicines Co. (NASDAQ:BPMC) Bought by Magnetar Financial LLCMagnetar Financial LLC purchased a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,084 shares of the biotechnology compaMarch 24, 2025 | marketbeat.com5,950 Shares in Blueprint Medicines Co. (NASDAQ:BPMC) Bought by Cibc World Markets CorpCibc World Markets Corp bought a new position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,950 shares of the biotechnology company's stock, valued at aMarch 23, 2025 | marketbeat.comProficio Capital Partners LLC Makes New $1.01 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC)Proficio Capital Partners LLC bought a new position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,600 shares of the biotechnology coMarch 22, 2025 | marketbeat.comBlueprint Medicines’ SWOT analysis: stock poised for growth amid challengesMarch 21, 2025 | investing.comBlueprint Medicines (NASDAQ:BPMC) Coverage Initiated by Analysts at Morgan StanleyMorgan Stanley began coverage on Blueprint Medicines in a report on Thursday. They set an "equal weight" rating and a $100.00 price objective on the stock.March 21, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Purchased by Intech Investment Management LLCIntech Investment Management LLC raised its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 70.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,571 shares of the biotechnology company's stock after buyingMarch 21, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Acquired by Swiss National BankSwiss National Bank increased its position in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,600 shares of the biotechnology company'March 21, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Blueprint Medicines Co. (NASDAQ:BPMC - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-three analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold rMarch 21, 2025 | marketbeat.comBlueprint Medicines assumed with an Equal Weight at Morgan StanleyMarch 20, 2025 | markets.businessinsider.comWolfe Research Begins Coverage on Blueprint Medicines (NASDAQ:BPMC)Wolfe Research started coverage on Blueprint Medicines in a report on Tuesday. They issued an "outperform" rating for the company.March 19, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. trimmed its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 91.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,023 shares of the biMarch 19, 2025 | marketbeat.comWolfe Research starts Blueprint Medicines at Outperform on bullish Ayvakit viewMarch 18, 2025 | msn.comBlueprint Medicines initiated with an Outperform at Wolfe ResearchMarch 18, 2025 | markets.businessinsider.comBlueprint Medicines (NASDAQ:BPMC) Now Covered by Analysts at Jefferies Financial GroupJefferies Financial Group started coverage on Blueprint Medicines in a report on Monday. They issued a "buy" rating and a $135.00 price objective for the company.March 18, 2025 | marketbeat.comWilliam Blair Investment Management LLC Purchases 269,896 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)William Blair Investment Management LLC raised its holdings in Blueprint Medicines Co. (NASDAQ:BPMC - Free Report) by 16.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,944,695 shares of the biotechnology company's stock aMarch 18, 2025 | marketbeat.comJefferies Initiates Coverage of Blueprint Medicines (BPMC) with Buy RecommendationMarch 17, 2025 | msn.com Remove Ads Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address BPMC Media Mentions By Week BPMC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼1.030.86▲Average Medical News Sentiment BPMC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼107▲BPMC Articles Average Week Remove Ads Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News Today ITCI News Today SMMT News Today GMAB News Today RDY News Today MRNA News Today VTRS News Today QGEN News Today ASND News Today ROIV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Blueprint Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPMC Stock Free BPMC Stock Alerts